Posts with tag Patents

Sort by Latest
A Guide to the UPC and the UP
The opening of the Unified Patent Court (UPC) on 1 June 2023 may be the most significant development in patent law internationally in the last 50 years. The UPC is an entirely new and truly multinational court with jurisdiction over disputes concerning most European patents in 17 EU Member States, covering a population of around 400 million. Following the opening of the UPC, “Unitary Patents” i.e. European patents with unitary effect throughout the 17 Contracting EU Member States, will...
June 9, 2023
2 min read
UK Supreme Court to assess plausibility of anaemia...
The UK Supreme Court has just confirmed that it will hear the...
December 23, 2022
3 min read
The Second Draft Patent Examination Guidelines on Patent...
TTThe second draft amendment to the Patent Examination...
November 3, 2022
4 min read
China’s First Supreme Court Patent Linkage Decision
On 5 August 2022, the Chinese Supreme Court (the “SPC”) handed down the second instance judgment on...
September 7, 2022
11 min read
Final(ly) Rules of Procedure of the UPC
Apart from the Unified Patent Court Agreement and a large body of further treaties, regulations,...
July 18, 2022
1 min read
New Draft Implementing Regulations propose key changes for pharmaceuticals in China
On 9 May 2022, the National Medical Products Administration (the “NMPA”) published the Implementing Regulations...
May 19, 2022
5 min read
The UPC Committees rule!
Start of the Provisional Application Phase and first committee meetings The Provisional...
April 7, 2022
12 min read
Illumina v MGI: Patents Court gives guidance on the skilled person, CGK, and insufficiency
In Illumina v Latvia MGI Tech (MGI) [2021] EWHC 57 (Pat), Birss J (as he...
March 26, 2021
9 min read
Indirect infringement in Spanish courts: a trend reversal and some teachings concerning infringement of second use medical claims
The specialised Section No. 15 of the Appeal Court of Barcelona has recently clarified what indirect...
January 22, 2021
4 min read